Overview
Nicole Lindenblatt practices in Zurich, Switzerland. Ms. Lindenblatt is rated as an Experienced expert by MediFind in the treatment of Necrotizing Fasciitis. Her top areas of expertise are Milroy Disease, Lymphedema, Lipedema, Mastectomy, and Bone Graft.
Her clinical research consists of co-authoring 137 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Necrotizing Fasciitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- LipedemaMs. Lindenblatt isDistinguished. Learn about Lipedema.
- LymphedemaMs. Lindenblatt isDistinguished. Learn about Lymphedema.
- Milroy DiseaseMs. Lindenblatt isDistinguished. Learn about Milroy Disease.
- Advanced
- Chromosome 13q DeletionMs. Lindenblatt isAdvanced. Learn about Chromosome 13q Deletion.
- Experienced
- Adult Soft Tissue SarcomaMs. Lindenblatt isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone GraftMs. Lindenblatt isExperienced. Learn about Bone Graft.
- Breast CancerMs. Lindenblatt isExperienced. Learn about Breast Cancer.
- Breast Enlargement In MalesMs. Lindenblatt isExperienced. Learn about Breast Enlargement In Males.
- Cerebral HypoxiaMs. Lindenblatt isExperienced. Learn about Cerebral Hypoxia.
- Compartment SyndromeMs. Lindenblatt isExperienced. Learn about Compartment Syndrome.